Biotech

All Articles

Capricor portions much more information for DMD therapy after starting BLA

.Capricor Therapeutics is actually taking a victory lap for their period 2 Duchenne muscular dystrop...

FDA locations Kezar lupus trial in grip complying with 4 individual deaths

.The FDA has actually placed Kezar Life Sciences' lupus test on hold after the biotech warned 4 fata...

Phase 3 Academic Stone trial hits SMA goal, sending stock up 200%

.A phase 3 trial of Scholar Stone's back muscular atrophy (SMA) applicant has actually attacked its ...

CAMP 4 is actually most recent to eye IPO, while Upstream define $182M plan

.RNA biotech CAMP4 Therapies has actually marked out plans for a $67 thousand IPO, along with inflam...

Galecto purchases leukemia medication, drops bone tissue cancer possession in pivot

.A year after the failing of an idiopathic lung fibrosis applicant delivered Galecto on a search for...

Judo throws down $100M to knock out kidney ailment

.Taking the mat is Judo Bio, a promising biotech armed with $one hundred million to build oligonucle...

AstraZeneca pays CSPC $100M for preclinical cardiovascular disease medicine

.AstraZeneca has settled CSPC Pharmaceutical Group $one hundred million for a preclinical cardiovasc...

Zephyrm finds Hong Kong IPO to cash phase 3 tissue treatment trials

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock exchange, declaring (PDF) for an...

Frazier Life Sciences collects $630M for small, mid-cap biotechs

.Frazier Daily life Sciences has actually sourced a better $630 thousand for its fund concentrated o...

GigaGen gets around $135M BARDA money to beat botox

.Antibody connoisseur GigaGen, a subsidiary of Spanish biopharma Grifols, is actually ramping up its...